1	Negative	negative	_	_	_	_	_	_	_
2	transcriptional	transcriptional	_	_	_	_	_	_	_
3	regulation	regulation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	interleukin	interleukin	_	_	_	_	_	_	_
7	2	2	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	IL-2	il-2	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	gene	gene	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	interference	interference	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	nuclear	nuclear	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	factors	factor	_	_	_	_	_	_	_
20	AP-1	ap-1	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	NF-AT	NF-AT	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	gene	gene	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	affected	affect	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	several	several	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	proteins	protein	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	asked	ask	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	dexamethasone	dexamethasone	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	Dex	Dex	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	cyclosporin	cyclosporin	_	_	_	_	_	_	_
10	A	a	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	CsA	CsA	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	inhibit	inhibit	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	gene	gene	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	interfering	interfere	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	activity	activity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	nuclear	nuclear	_	_	_	_	_	_	_
25	proteins	protein	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	bind	bind	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	IL-2	il-2	_	_	_	_	_	_	_
31	promoter	promoter	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	extracts	extract	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	primary	primary	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	analyzed	analyze	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	electrophoretic	electrophoretic	_	_	_	_	_	_	_
12	DNA	dna	_	_	_	_	_	_	_
13	mobility	mobility	_	_	_	_	_	_	_
14	shift	shift	_	_	_	_	_	_	_
15	assays	assay	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	Dex	Dex	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	CsA	CsA	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	AP-1	ap-1	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	NF-AT	NF-AT	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NF-kB	NF-kB	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	OCT-1/OAF	OCT-1/OAF	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	their	their	_	_	_	_	_	_	_
24	corresponding	correspond	_	_	_	_	_	_	_
25	sites	site	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	gene	gene	_	_	_	_	_	_	_
30	promoter	promoter	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	correlate	correlate	_	_	_	_	_	_	_
3	changes	change	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	vitro	vitro	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	transcriptional	transcriptional	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	vivo	vivo	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	define	define	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	structural	structural	_	_	_	_	_	_	_
19	requirements	requirement	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	repression	repression	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	we	we	_	_	_	_	_	_	_
26	used	use	_	_	_	_	_	_	_
27	transient	transient	_	_	_	_	_	_	_
28	DNA	dna	_	_	_	_	_	_	_
29	transfections	transfection	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Jurkat	Jurkat	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	transfected	transfecte	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	plasmids	plasmid	_	_	_	_	_	_	_
7	containing	contain	_	_	_	_	_	_	_
8	either	either	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	intact	intact	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	its	its	_	_	_	_	_	_	_
15	AP-1	ap-1	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	NF-AT	NF-AT	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	NF-kB	NF-kB	_	_	_	_	_	_	_
21	motifs	motif	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Dex	Dex	_	_	_	_	_	_	_
2	inhibited	inhibit	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	promoter	promoter	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	AP-1	ap-1	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	NF-AT	NF-AT	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NF-kB	NF-kB	_	_	_	_	_	_	_
16	plasmids	plasmid	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	CsA	CsA	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	NF-AT	NF-AT	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	AP-1	ap-1	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	NF-kB	nf-kb	_	_	_	_	_	_	_
19	plasmids	plasmid	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	lymphocytes	lymphocyte	_	_	_	_	_	_	_
9	both	both	_	_	_	_	_	_	_
10	Dex	Dex	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	CsA	CsA	_	_	_	_	_	_	_
13	inhibited	inhibit	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	through	through	_	_	_	_	_	_	_
18	interference	interference	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	factors	factor	_	_	_	_	_	_	_
22	AP-1	ap-1	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	NF-AT	NF-AT	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	propose	propose	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	while	while	_	_	_	_	_	_	_
6	maximum	maximum	_	_	_	_	_	_	_
7	inhibition	inhibition	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	involve	involve	_	_	_	_	_	_	_
10	interaction	interaction	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	both	both	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factors	factor	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	AP-1	ap-1	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	primary	primary	_	_	_	_	_	_	_
20	target	target	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	Dex	Dex	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

